Skip to content

Drug interactions

Ketorolac intranasal + Pirbuterol

Severity: Minor

Ketorolac intranasal and Pirbuterol: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Intranasal ketorolac has low systemic exposure and no recognised potassium-related interaction with an inhaled beta-agonist. NSAIDs can rarely cause hyperkalemia in renal impairment, but this is unlikely to be meaningful here.

What this interaction means in plain words

Ketorolac intranasal and Pirbuterol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

No established mechanism; opposing potassium effects are theoretical only.

What to do

No specific action is needed; check potassium only if renal impairment or other relevant risk factors are present.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ketorolac intranasal and Pirbuterol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ketorolac intranasal with Pirbuterol?

MediHelp rates the interaction as minor. Ketorolac intranasal and Pirbuterol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Intranasal ketorolac has low systemic exposure and no recognised potassium-related interaction with an inhaled beta-agonist. NSAIDs can rarely cause hyperkalemia in renal impairment, but this is unlikely to be meaningful here.

How serious is the interaction between Ketorolac intranasal and Pirbuterol?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No specific action is needed; check potassium only if renal impairment or other relevant risk factors are present.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in